Methods to increase participation in organised screening programs: A systematic review

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Camilloni, Laura ^a   Ferroni, Eliana ^b   Cendales, Beatriz Jimenez ^a   Pezzarossi, Annamaria ^c   Furnari, Giacomo ^a   Borgia, Piero ^a   Guasticchi, Gabriella ^a   Rossi, Paolo Giorgi ^c  

^a Laziosanità Agency for Public Health Lazio Region   (Italy)

^b Epidemiology Department   (Italy)

^c PATHOLOGY UNIT   (Italy)

Author keywords

Cancer; Mass screening; Participation; Systematic review

Indexed keywords

ADULT; AGED; BREAST TUMOR; COLORECTAL TUMOR; EUROPE; FEMALE; HEALTH PROMOTION; HUMAN; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PATIENT COMPLIANCE; REMINDER SYSTEM; REVIEW; UTERINE CERVIX TUMOR;

ADULT; AGED; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; EUROPE; FEMALE; HEALTH PROMOTION; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT COMPLIANCE; REMINDER SYSTEMS; UTERINE CERVICAL NEOPLASMS;

EID: 84877635879     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-464     Document Type: Review

References (107)

1. Council Recommendation 2 December 2003 on cancer screening. European Council, Off J Eur Union 2003 2003/878/EC
2. Cancer society guidelines and issues in cancer screening cancer screening in the United States, 2010: a review of current American. Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW, CA Cancer J Clin 2010 60 99 119 10.3322/caac.20063 20228384
3. Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, Wiener H, Herbert A, von Karsa L, European Guidelines for Quality Assurance in Cervical Cancer Screening Luxembourg: Office for Official Publications of the European Communities, European Commission, 2 2008 1 291
4. IARC, Breast cancer screening. IARC Hanbooks of Cancer Prevention, Volume 7 Lyon: IARC Press 2002
5. European guidelines for quality assurance in colorectal cancer screening and diagnosis Luxembourg: European Commission, Segnan N, Patnick J, Karsa L von, 2010
6. Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. Quinn M, Babb P, Jones J, Allen E, BMJ 1999 318 904 908 10.1136/bmj.318.7188.904 10102852
7. The cervical cancer epidemic that screening has prevented in the UK. Peto J, Gilham C, Fletcher O, Matthews FE, Lancet 2004 364 249 256 10.1016/S0140-6736(04)16674-9 15262102
8. Cervical cancer screening is effective-the Finnish experience. Anttila A, Copenhagen: Entre Nous, WHO Regional Office 2007 64 26 28
9. Comparison of screening mammography in the United States and the United Kingdom. Smith-Bindman R, Chu PW, Miglioretti DL, Sickles EA, Blanks R, Ballard-Barbash R, Bobo JK, Lee NC, Wallis MG, Patnick J, Kerlikowske K, JAMA 2003 290 2129 2137 10.1001/jama.290.16.2129 14570948
10. Von Karsa L, Anttila A, Ronco G, Ponti A, Malila N, Arbyn M, Segnan N, Castillo-Beltran M, Boniol M, Ferlay J, Hery C, Sauvaget C, Voti L, Autier P, Cancer Screening in the European Union. Report on the Implementation of the Council Recommendation on Cancer Screening-First Report. Luxembourg: European Communities 2008
11. Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands. Bos AB, Rebolj M, Habbema JD, van Ballegooijen M, Int J Cancer 2006 119 2372 2375 10.1002/ijc.22114 16858676
12. Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy. Giorgi Rossi P, Ricciardi A, Cohet C, Palazzo F, Furnari G, Valle S, Largeron N, Federici A, BMC Public Health 2009 9 71 10.1186/1471-2458-9-71 19243586
13. Socio-economic inequalities in breast and cervical cancer screening practices in Europe: influence of the type of screening program. Palència L, Espelt A, Rodríguez-Sanz M, Puigpinós R, Pons-Vigués M, Pasarín MI, Spadea T, Kunst AE, Borrell C, Int J Epidemiol 2010 39 757 765 10.1093/ije/dyq003 20176587
14. Garantire la partecipazione consapevole. Federici A, Poletti P, Guarino A, Serantoni G, Rogate C, Screening: profilo complesso di assistenza Rome: Il Pensiero Scientifico Editore, Federici A, 2007 252 259
15. To nudge or not to nudge: cancer screening programmes and the limits of libertarian paternalism. Ploug T, Holm S, Brodersen J, J Epidemiol Community Health 2012 66 1193 6 10.1136/jech-2012-201194 22766778
16. The determinants of screening uptake and interventions for increasing uptake: a systematic review. Jepson R, Clegg A, Forbes C, Lewis R, Sowden A, Kleijnen J, Health Technol Assess 2000 4 vii 1-133 11070816
17. Strategies for increasing the participation of women in community breast cancer screening. Bonfill Cosp X, Marzo Castillejo M, Pladevall Vila M, Martí J, Emparanza JI, Cochrane Database Syst Rev 2001 1 CD002943
18. Interventions targeted at women to encourage the uptake of cervical screening. Everett T, Bryant A, Griffin MF, Martin-Hirsch PP, Forbes CA, Jepson RG, Cochrane Database Syst Rev 2011 5 CD002834
19. Interventions targeted at women to encourage the uptake of cervical screening. Forbes CA, Jepson RG, Martin-Hirsch PPL, Cochrane Database Syst Rev 2002 3 CD002834
20. Personalised risk communication for informed decision making about taking screening tests. Edwards AGK, Evans R, Dundon J, Haigh S, Hood K, Elwyn GJ, Cochrane Database Syst Rev 2006 4 CD001865
21. Decision aids for people facing health treatment or screening decisions. O'Connor AM, Bennett CL, Stacey D, Barry M, Col NF, Eden KB, Entwistle VA, Fiset V, Holmes-Rovner M, Khangura S, Llewellyn-Thomas H, Rovner D, Cochrane Database Syst Rev 2009 3 CD001431
22. A systematic review of interventions to increase breast and cervical cancer screening uptake among Asian women. Lu M, Moritz S, Lorenzetti D, Sykes L, Straus S, Quan H, BMC Public Health 2012 12 413 10.1186/1471-2458-12-413 22676147
23. The impact of screening on future health-promoting behaviours and health beliefs: a systematic review. Bankhead CR, Brett J, Bukach C, Webster P, Stewart-Brown S, Munafo M, Austoker J, Health Technol Assess 2003 7 1 92 14670218
24. The impact of interventions to improve attendance in female cancer screening among lower socioeconomic groups: a review. Spadea T, Bellini S, Kunst A, Stirbu I, Costa G, Prev Med 2010 50 159 164 10.1016/j.ypmed.2010.01.007 20093138
25. Methods to increase participation in cancer screening programmes. Giorgi Rossi P, Camilloni L, Cogo C, Federici A, Ferroni E, Furnari G, Giordano L, Grazzini G, Iossa A, Jimenez B, Palazzi M, Palazzo F, Spadea T, Senore C, Borgia P, Guasticchi G, Epidemiol Prev 2012 36 Suppl 1 1 104 23139155
26. How to increase uptake in oncologic screening: a systematic review of studies comparing population-based screening programs and spontaneous access. Ferroni E, Camilloni L, Jimenez B, Furnari G, Borgia P, Guasticchi G, Giorgi Rossi P, Working Group Methods to increase participation, Prev Med 2012 55 587 96 10.1016/j.ypmed.2012.10.007 23064024
27. Meta-analysis: Adherence to colorectal cancer screening and the detection rate for advanced neoplasia, according to the type of screening test. Hassan C, Giorgi Rossi P, Camilloni L, Rex DK, Jimenez Cendales B, Ferroni E, Borgia P, Zullo A, Guasticchi G, HTA Group, Alim Pharm Ther 2012 36 929 40 10.1111/apt.12071
28. The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials. Moher D, Schulz KF, Altman D, JAMA 2001 285 1987 1991 10.1001/jama.285.15.1987 11308435
29. 10 questions to help you make sense of randomised controlled trials. Tool adapted by ©Milton Keynes Primary Care Trust 2002 from Guyatt GH, Sackett DL, and Cook DJ, Users' guides to the medical literature. II. How to use an article about therapy or prevention. Critical Appraisal Skills Programme (CASP), JAMA 1994 271 59 63 10.1001/jama.1994.03510250075039 8258890
30. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, STROBE Initiative, Lancet 2007 370 1453 1457 10.1016/S0140-6736(07)61602-X 18064739
31. A large population-based randomized controlled trial to increase attendance at screening for cervical cancer. Eaker S, Adami HO, Granath F, Wilander E, Sparén P, Cancer Epidemiol Biomarkers Prev 2004 13 346 354 15006907
32. How much does a reminder letter increase cervical screening among under-screened women in NSW? Morrell S, Taylor R, Zeckendorf S, Niciak A, Wain G, Ross J, Aust N Z J Public Health 2005 29 78 84 10.1111/j.1467-842X.2005. tb00753.x 15782877
33. Promoting mammography use through progressive interventions: is it effective? King ES, Rimer BK, Seay J, Balshem A, Engstrom PF, Am J Public Health 1994 84 104 106 10.2105/AJPH.84.1.104 8279593
34. Using physician correspondence and postcard reminders to promote mammography use. Taplin SH, Anderman C, Grothaus L, Curry S, Montano D, Am J Public Health 1994 84 571 574 10.2105/AJPH.84.4.571 8154558
35. Recruitment to mammography screening: a randomised trial and meta-analysis of invitation letters and telephone calls. Page A, Morrell S, Chiu C, Taylor R, Tewson R, Aust N Z J Public Health 2006 30 111 118 10.1111/j.1467-842X.2006.tb00101.x 16681329
36. Improving fecal occult blood testing compliance using a mailed educational reminder. Lee JK, Reis V, Liu S, Conn L, Groessl EJ, Ganiats TG, Ho SB, J Gen Intern Med 2009 24 1192 1197 10.1007/s11606-009-1087-5 19774423
37. Does telephone contact with a physician's office staff improve mammogram screening rates? Bodiya A, Vorias D, Dickson HA, Fam Med 1999 31 324 326 10407709
38. Telephone counseling and attendance in a national mammography-screening program: a randomized controlled trial. Hegenscheid K, Hoffmann W, Fochler S, Domin M, Weiss S, Hartmann B, Bick U, Hosten N, Am J Prev Med 2011 41 421 427 10.1016/j.amepre.2011.06.040 21961470
39. Facility-based in-reach strategies to promote annual mammograms. Mayer JA, Clapp EJ, Bartholomew S, Offer J, Am J Prev Med 1994 10 353 356 7880555
40. Strategies for increasing mammography screening in primary care in Chile: results of a randomized clinical trial. Püschel K, Coronado G, Soto G, Gonzalez K, Martinez J, Holte S, Thompson B, Cancer Epidemiol Biomarkers Prev 2010 19 2254 2261 10.1158/1055-9965.EPI-10-0313 20826832
41. Effects of a mammography decision-making intervention at 12 and 24 months. Rimer BK, Halabi S, Sugg Skinner C, Lipkus IM, Strigo TS, Kaplan EB, Samsa GP, Am J Prev Med 2002 22 247 257 10.1016/S0749-3797(02)00417-8 11988381
42. Participation in breast cancer screening: randomised controlled trials of doctors' letters and of telephone reminders. Richardson A, Williams S, Elwood M, Bahr M, Medlicott T, Aust J Public Health 1994 18 290 292 7841259
43. The safety net: a cost-effective approach to improving breast and cervical cancer screening. Vogt TM, Glass A, Glasgow RE, La Chance PA, Lichtenstein E, J Womens Health (Larchmt) 2003 12 789 798 10.1089/ 154099903322447756
44. Evaluation of three methods for improving mammography rates in a managed care plan. Davis NA, Nash E, Bailey C, Lewis MJ, Rimer BK, Koplan JP, Am J Prev Med 1997 13 298 302 9236968
45. Finding the minimal intervention needed for sustained mammography adherence. Gierisch JM, DeFrank JT, Bowling JM, Rimer BK, Matuszewski JM, Farrell D, Skinner CS, Am J Prev Med 2010 39 334 344 10.1016/j.amepre.2010.05. 020 20837284
46. Promotion of cervical screening among nonattendees: a partial cost-effectiveness analysis. Oscarsson MG, Benzein EG, Wijma BE, Carlsson PG, Eur J Cancer Prev 2007 16 559 563 10.1097/CEJ.0b013e3280145e60 18090130
47. A prospective randomized study of two reminding strategies: telephone versus mail in the screening of cervical cancer in women who did not initially respond. Heranney D, Fender M, Velten M, Baldauf JJ, Acta Cytol 2011 55 334 340 10.1159/000327527 21791902
48. Screening HMO women overdue for both mammograms and pap tests. Valanis BG, Glasgow RE, Mullooly J, Vogt TM, Whitlock EP, Boles SM, Smith KS, Kimes TM, Prev Med 2002 34 40 50 10.1006/pmed.2001.0949 11749095
49. Behavioral interventions to increase adherence in colorectal cancer screening. Myers RE, Ross EA, Wolf TA, Balshem A, Jepson C, Millner L, Med Care 1991 29 1039 1050 10.1097/00005650-199110000-00009 1921523
50. Modeling adherence to colorectal cancer screening. Myers RE, Ross E, Jepson C, Wolf T, Balshem A, Millner L, Leventhal H, Prev Med 1994 23 142 151 10.1006/pmed.1994.1020 8047519
51. Maximizing compliance with hemoccult screening for colon cancer in clinical practice. Thompson RS, Michnich ME, Grey J, Friedlander L, Gilson B, Med Care 1986 24 904 914 10.1097/00005650-198610000-00004 3762240
52. Randomized controlled trial of mammography intervention in insured very low-income women. Ahmed NU, Haber G, Semenya KA, Hargreaves MK, Cancer Epidemiol Biomarkers Prev 2010 19 1790 1798 10.1158/1055-9965.EPI-10-0141 20587669
53. Can the uptake of breast screening by Asian women be increased? A randomized controlled trial of a linkworker intervention. Hoare T, Thomas C, Biggs A, Booth M, Bradley S, Friedman E, J Public Health Med 1994 16 179 185 7946492
54. Cost-effectiveness comparison of five interventions to increase mammography screening. Saywell RM Jr, Champion VL, Skinner CS, McQuillen D, Martin D, Maraj M, Prev Med 1999 29 374 382 10.1006/pmed.1999.0568 10564629
55. A randomized controlled trial comparing three invitation strategies in a breast cancer screening program. Segura JM, Castells X, Casamitjana M, Macià F, Porta M, Katz SJ, Prev Med 2001 33 325 332 10.1006/pmed.2001. 0891 11570837
56. A randomised trial of the use of print material and personal contact to improve mammography uptake among screening non-attenders in Singapore. Seow A, Straughan P, Ng E, Lee HP, Ann Acad Med Singapore 1998 27 838 842 10101560
57. Breast screening: a randomised controlled trial in UK general practice of three interventions designed to increase uptake. Sharp DJ, Peters TJ, Bartholomew J, Shaw A, J Epidemiol Commun Health 1996 50 72 76 10.1136/jech.50.1.72
58. Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing. Stokamer CL, Tenner CT, Chaudhuri J, Vazquez E, Bini EJ, J Gen Intern Med 2005 20 278 282 10.1111/j.1525-1497. 2005.40023.x 15836533
59. The effect of patient reminders on the use of screening mammography in an urban health department primary care setting. Simon MS, Gimotty PA, Moncrease A, Dews P, Burack RC, Breast Cancer Res Treat 2001 65 63 70 10.1023/A: 1006410711370 11245341
60. Tailored written invitations for second round breast cancer screening: a randomised controlled trial. Meldrum P, Turnbull D, Dobson HM, Colquhoun C, Gilmour WH, McIlwaine GM, J Med Screen 1994 1 245 248 8790529
61. Promoting participation in a population screening program for breast and cervical cancer: a randomized trial of different invitation strategies. Segnan N, Senore C, Giordano L, Ponti A, Ronco G, Tumori 1998 84 348 353 9678615
62. An advance notification letter increases participation in colorectal cancer screening. Cole SR, Smith A, Wilson C, Turnbull D, Esterman A, Young GP, J Med Screen 2007 14 73 75 10.1258/096914107781261927 17626705
63. Advance notification letters increase adherence in colorectal cancer screening: a population-based randomized trial. van Roon AH, Hol L, Wilschut JA, Reijerink JC, van Vuuren AJ, van Ballegooijen M, Habbema JD, van Leerdam ME, Kuipers EJ, Prev Med 2011 52 448 451 10.1016/j.ypmed.2011.01.032 21457725
64. Screening for colorectal cancer by once only sigmoidoscopy: a feasibility study in Turin, Italy. Senore C, Segnan N, Rossini FP, Ferraris R, Cavallero M, Coppola F, Pennazio M, Atkin WS, J Med Screen 1996 3 72 78 8849763
65. Improving uptake of cervical cancer screening in women with prolonged history of non-attendance for screening: a randomized trial of enhanced invitation methods. Stein K, Lewendon G, Jenkins R, Davis C, J Med Screen 2005 12 185 189 10.1258/096914105775220741 16417695
66. General practitioners and mammographic screening uptake: influence of different modalities of general practitioner participation. Giorgi D, Giordano L, Senore C, Merlino G, Negri R, Cancian M, Lerda M, Segnan N, Del Turco MR, Working Group. Tumori 2000 86 124 129
67. Can postal prompts from general practitioners improve the uptake of breast screening? A randomised controlled trial in one east London general practice. O'Connor AM, Griffiths CJ, Underwood MR, Eldridge S, J Med Screen 1998 5 49 52 10.1136/jms.5.1.49 9575461
68. A randomised controlled trial of strategies to prompt attendance for a Pap smear. Bowman J, Sanson-Fisher R, Boyle C, Pope S, Redman S, J Med Screen 1995 2 211 218 8719151
69. Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner. Cole SR, Young GP, Byrne D, Guy JR, Morcom J, J Med Screen 2002 9 147 152 10.1136/jms.9.4.147 12518003
70. Primary care endorsement letter and a patient leaflet to improve participation in colorectal cancer screening: results of a factorial randomised trial. Hewitson P, Ward AM, Heneghan C, Halloran SP, Mant D, Br J Cancer 2011 105 475 480 10.1038/bjc.2011.255 21829202
71. The effect on compliance of a health education leaflet in colorectal cancer screening in general practice in central England. Hart AR, Barone TL, Gay SP, Inglis A, Griffin L, Tallon CA, Mayberry JF, J Epidemiol Commun Health 1997 51 187 191 10.1136/jech.51.2.187
72. Can health education increase uptake of cervical smear testing among Asian women? McAvoy BR, Raza R, BMJ 1991 302 6780 833 836 10.1136/bmj.302.6780. 833 1958248
73. Randomised trial of compliance with screening for colorectal cancer. Nichols S, Koch E, Lallemand RC, Heald RJ, Izzard L, Machin D, Mullee MA, Br Med J Clin Res Educ 1986 293 107 110 10.1136/bmj.293.6539.107
74. A comparison of methods for increasing compliance within a general practitioner based screening project for colorectal cancer and the effect on practitioner workload. Pye G, Christie M, Chamberlain JO, Moss SM, Hardcastle JD, J Epidemiol Commun Health 1988 42 66 71 10.1136/jech.42.1.66
75. Impact of an educational video-based strategy on the behavior process associated with colorectal cancer screening: A randomized controlled study. Gimeno-García AZ, Quintero E, Nicolás-Pérez D, Parra-Blanco A, Jiménez-Sosa A, Cancer Epidemiol 2009 33 216 222 10.1016/j.canep. 2009.08.003 19747893
76. The impact of mailing psychoeducational materials to women with abnormal mammograms. Lerman C, Ross E, Boyce A, Gorchov PM, McLaughlin R, Rimer B, Engstrom P, Am J Public Health 1992 82 729 730 10.2105/AJPH.82.5.729 1566953
77. The impact of tailored interventions on a community health center population. Rimer B, Patient Educ Counsel 1999 37 125 140 10.1016/S0738-3991(98) 00122-0
78. Cervical cancer screening: a comparison of recruitment strategies among older women. Mitchell H, Hirst S, Cockburn J, Reading DJ, Staples MP, Medley G, Med J Aust 1991 155 79 82 1857311
79. A collaborative approach to cervical cancer screening. Brown W, Byles J, J Med Screen 1996 3 146 153 8946310
80. Two sequential randomized trials of community participation to recruit women for mammographic screening. Clover K, Redman S, Forbes J, Sanson-Fisher R, Callaghan T, Prev Med 1996 25 126 134 10.1006/pmed.1996.0038 8860277
81. Strategies to encourage mammography use among women in senior citizens' housing facilities. King E, Rimer BK, Benincasa T, Harrop C, Amfoh K, Bonney G, Kornguth P, Demark-Wahnefried W, Strigo T, Engstrom P, J Cancer Edu. 1998 13 108 115
82. The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600). Giorgi Rossi P, Marsili LM, Camilloni L, Iossa A, Lattanzi A, Sani C, Di Pierro C, Grazzini G, Angeloni C, Capparucci P, Pellegrini A, Schiboni ML, Sperati A, Confortini M, Bellanova C, D'Addetta A, Mania E, Visioli CB, Sereno E, Carozzi F, Self-Sampling Study Working Group, Br J Cancer 2011 104 248 254 10.1038/sj.bjc.6606040 21179038
83. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. Gok M, Heideman DA, van Kemenade FJ, Berkhof J, Rozendaal L, Spruyt JW, Voorhorst F, Beliën JA, Babovic M, Snijders PJ, Meijer CJ, BMJ 2010 340 1040 10.1136/bmj.c1040 20223872
84. Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program. Gok M, van Kemenade FJ, Heideman DA, Berkhof J, Rozendaal L, Spruyt JW, Beliën JA, Babovic M, Snijders PJ, Meijer CJ, Int J Cancer 2012 130 1128 1135 10.1002/ijc.26128 21484793
85. HPV-Hr detection by home self sampling in women not compliant with pap test for cervical cancer screening. Results of a pilot programme in Bouches-du-Rhône. Piana L, Leandri FX, Le Retraite L, Heid P, Tamalet C, Sancho-Garnier H, Bull Cancer 2011 98 723 731 21700548
86. HPV self-sampling as an alternative strategy in non-attenders for cervical screening-a randomised controlled trial. Szarewski A, Cadman L, Mesher D, Austin J, Ashdown-Barr L, Edwards R, Lyons D, Walker J, Christison J, Frater A, Waller J, Br J Cancer 2011 104 915 920 10.1038/bjc.2011.48 21343937
87. Self-sampling versus reminder letter: effects on cervical cancer screening attendance and coverage in Finland. Virtanen A, Anttila A, Luostarinen T, Nieminen P, Int J Cancer 2011 128 2681 2687 10.1002/ijc.25581 20669228
88. Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial. Virtanen A, Nieminen P, Luostarinen T, Anttila A, Cancer Epidemiol Biomarkers Prev 2011 20 1960 1969 10.1158/1055-9965.EPI-11-0307 21752985
89. Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study. Wikstrom I, Lindell M, Sanner K, Wilander E, Br J Cancer 2011 105 337 339 10.1038/bjc.2011.236 21730977
90. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, Salmerón J, Uribe P, Velasco-Mondragón E, Nevarez PH, Acosta RD, Hernández-Avila M, Lancet 2011 378 1868 1873 10.1016/S0140-6736(11)61522-5 22051739
91. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening. Church TR, Yeazel MW, Jones RM, Kochevar LK, Watt GD, Mongin SJ, Cordes JE, Engelhard D, J Natl Cancer Inst 2004 96 770 780 10.1093/jnci/djh134 15150305
92. Comparative educational approaches to screening for colorectal cancer. Elwood TW, Erickson A, Lieberman S, Am J Public Health 1978 68 135 138 10.2105/AJPH.68.2.135 415624
93. Direct mailing of faecal occult blood tests for colorectal cancer screening: a randomised population study from Central Italy. Giorgi Rossi P, Grazzini G, Anti M, Baiocchi D, Barca A, Bellardini P, Brezzi S, Camilloni L, Falini P, Maccallini V, Mantellini P, Romeo D, Rubeca T, Venditti MA, J Med Screen 2011 18 121 127 10.1258/jms.2011.011009 22045820
94. Patient compliance with colorectal cancer screening in general practice. Mant D, Fuller A, Northover J, Astrop P, Chivers A, Crockett A, Clements S, Lawrence M, Br J Gen Pract 1992 42 18 20 1586526
95. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. Segnan N, Senore C, Andreoni B, Arrigoni A, Bisanti L, Cardelli A, Castiglione G, Crosta C, DiPlacido R, Ferrari A, Ferraris R, Ferrero F, Fracchia M, Gasperoni S, Malfitana G, Recchia S, Risio M, Rizzetto M, Saracco G, Spandre M, Turco D, Turco P, Zappa M, SCORE2 Working Group-Italy, J Natl Cancer Inst 2005 97 347 357 10.1093/jnci/dji050 15741571
96. Randomised trial of two strategies offering women mobile screening for breast cancer. Williams EM, Vessey MP, BMJ 1989 299 158 159 10.1136/bmj.299. 6692.158 2504357
97. Cervical screening in general practice. Pritchard DA, Straton JA, Hyndman J, Austr J Public Health 1995 19 167 172
98. Cervical cytology screening: a comparison of two call systems. Wilson A, Leeming A, BMJ 1987 295 181 182 3115368
99. The role of GPs in increasing compliance to colorectal cancer screening: a randomised controlled trial (Italy). Federici A, Giorgi Rossi P, Bartolozzi F, Farchi S, Borgia P, Guasticchi G, Cancer Causes Control 2006 17 45 52 10.1007/s10552-005-0380-9 16411052
100. Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies. Pippa G, Ferrara M, Valle S, Diego B, Barca A, Apuzzo M, Bazuro ME, Tammaro G, Federici A, Recenti Prog Med 2009 100 348 351 19725474
101. Cost-effectiveness of increasing access to mammography through mobile mammography for older women. Naeim A, Keeler E, Bassett LW, Parikh J, Bastani R, Reuben DB, J Am Geriatr Soc 2009 57 285 290 10.1111/j.1532-5415.2008.02105.x 19170780
102. High-risk HPV testing on self-sampled versus clinician-collected specimens: A review on the clinical accuracy and impact on population attendance in cervical cancer screening. Snijders PJ, Verhoef VM, Arbyn M, Ogilvie G, Minozzi S, Banzi R, van Kemenade FJ, Heideman DA, Meijer CJ, Int J Cancer 2013 132 2223 2236 10.1002/ijc.27790 22907569
103. How should we measure informed choice? The case of cancer screening. Jepson RG, Hewison J, Thompson AG, Weller D, J Med Ethics 2005 31 192 196 10.1136/jme.2003.005793 15800356
104. NHS Breast Screening Programme http://www.cancerscreening.nhs.uk/ breastscreen/
105. NHS Cervical Screening Programme, http://www.cancerscreening.nhs.uk/ cervical/index.html
106. NHS Bowel Cancer Screening Programme http://www.cancerscreening.nhs.uk/ bowel/index.html
107. Attendance to cervical cancer screening in family practices in The Netherlands. Hermens RP, Tacken MA, Hulscher ME, Braspenning JC, Grol RP, Prev Med 2000 30 35 42 10.1006/pmed.1999.0603 10642458